Table 1 Baseline characteristics of study populations with Staphylococcus aureus endocarditis
Characteristics | Hemodialysis (n = 121) | Non-ESKD (n = 190) | Total (n = 311) | P value |
|---|---|---|---|---|
Follow-up (years) | 1.8 ± 2.4 | 2.6 ± 2.9 | 2.3 ± 2.8 | |
Age (years) | 60.5 ± 15.2 | 62.3 ± 16.2 | 61.6 ± 15.8 | 0.301 |
Female (N) | 47 (39%) | 52 (27.4%) | 99 (31.8%) | 0.045 |
Age (years) | 57.9 ± 14.7 | 66.6 ± 17.4 | 62.5 ± 16.5 | 0.004 |
Male (N) | 74 (61%) | 138 (72.6%) | 212 (68.2%) | 0.045 |
Age (years) | 62.1 ± 15.3 | 60.6 ± 15.6 | 61.2 ± 15.5 | 0.417 |
Pre-existing Heart valve disease | ||||
Aortic valve | 17 (14.1%) | 40 (21.1%) | 57 (18.3%) | 0.134 |
Mitral valve | 12 (10%) | 22 (11.6%) | 34 (11%) | 0.712 |
Comorbidity | ||||
Myocardial infarction | 17 (14.1%) | 22 (11.6%) | 39 (12.5%) | 0.598 |
Diabetes mellitus | 43 (35.5%) | 23 (12.1%) | 66 (21.2%) | < 0.001 |
Chronic obstructive lung disease | 7 (5.8%) | 7 (3.7%) | 14 (4.5%) | 0.410 |
Peripheral vascular disease | 19 (15.7%) | 12 (6.3%) | 31 (10%) | 0.012 |
Ischemic heart disease | 32 (26.5%) | 48 (25.3%) | 80 (25.7%) | 0.894 |
Cardiac arrythmia disorder | 30 (24.8%) | 36 (19%) | 66 (21.2%) | 0.255 |
Atrial flutter | 25 (20.7%) | 26 (13.7%) | 51 (16.4%) | 0.118 |
Chronic heart failure | 30 (24.8%) | 32 (16.8%) | 62 (20%) | 0.109 |
aChronic kidney disease stage | ||||
1 | 51 (26.8%) | |||
2 | 52 (27.4%) | |||
3 | 55 (28.9%) | |||
4 | 25 (13.2%) | |||
5 | 7 (3.7%) | |||
5 dialysis | 121 (100%) | – | ||